Sergey Yu. Golokhvastov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Sergey Yu. Golokhvastov has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Nikolay Vasil’yEvich Tsygan
Kirov Military Medical Academy
10 shared publications - Igor’ Vyacheslavovich Litvinenko
S.M. Kirov Military Medical Academy
7 shared publications - Miroslav Mihailovich Odinak
Kirov Military Medical Academy
7 shared publications - Aleksander V. Ryabtsev
S.M. Kirov Military Medical Academy
3 shared publications - Ruslan V. Andreev
Military Medical Academy
3 shared publications Голохвастов Сергей Юрьевич
Военно-медицинская академия
3 shared publications
Latest Publications
- 13 December 2025
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 30 (5)
Anti-N-METHYL-D-aspartate receptor encephalitis, recurrent course
Anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAR-encephalitis) was first described as an immune-mediated disorder of behavior and cognitive functions in patients with ovarian teratoma. Subsequently, it was recognized as a separate type of autoimmune encephalitis with a characteristic clinical picture and the possibility of development in the absence of data on tumor formations. The course can have both monophase and recurrent variants with periods of improvement or stabilization of the condition and subsequent progression of the disease. The article presents a clinical observation of a patient with a relapse of the disease 2 years later. The diagnosis of anti-NMDAR-encephalitis was established based on the presence of antibodies to NMDA receptor epitopes in the patient's cerebrospinal fluid, both at the onset of the disease and during the relapse. According to foreign literature, the incidence of recurrent anti-NMDAR-encephalitis varies from 12% to 24%, depending on the study, which requires additional monitoring of patients with this diagnosis.
- 13 December 2025
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 30 (5)
Anti-N-METHYL-D-aspartate receptor encephalitis, recurrent course
Anti-N-methyl-D-aspartate receptor encephalitis (anti-NMDAR-encephalitis) was first described as an immune-mediated disorder of behavior and cognitive functions in patients with ovarian teratoma. Subsequently, it was recognized as a separate type of autoimmune encephalitis with a characteristic clinical picture and the possibility of development in the absence of data on tumor formations. The course can have both monophase and recurrent variants with periods of improvement or stabilization of the condition and subsequent progression of the disease. The article presents a clinical observation of a patient with a relapse of the disease 2 years later. The diagnosis of anti-NMDAR-encephalitis was established based on the presence of antibodies to NMDA receptor epitopes in the patient's cerebrospinal fluid, both at the onset of the disease and during the relapse. According to foreign literature, the incidence of recurrent anti-NMDAR-encephalitis varies from 12% to 24%, depending on the study, which requires additional monitoring of patients with this diagnosis.
- Open Access
- 5 November 2025
- Published by ECO-Vector LLC (Publications) in Russian Military Medical Academy Reports
- Vol. 44 (4) , 367-380
Ischemic stroke in combat conditions. Vasculocerebral injury
During armed conflicts, the incidence of ischemic stroke among military personnel increases substantially compared with peacetime. In addition to the elevated risk of combat-related injuries, military service members are exposed to intense physical and emotional stress and extreme environmental factors, which contribute to the toll of both common (atherosclerotic arterial changes, diabetes mellitus, obesity, cardiovascular diseases) and specific risk factors more typical of young adults (cardiac sources of embolism, non-inflammatory and inflammatory arteriopathies, coagulation disorders), as well as generate additional stroke risk factors unique to combat conditions. Firearm injuries have a special place in the pathogenesis of combat-related ischemic stroke. We have proposed and substantiated the term vasculocerebral injury. It is a distinct type of combat firearm injury, representing a cascade of sequential interrelated pathological changes occurring in the damaged major precerebral arteries (aorta, brachiocephalic trunk, common and internal carotid arteries, vertebral arteries), cerebral arteries, their vascular territories, blood cellular elements, and surrounding tissues as a result of the complex damaging effect of a high-energy projectile (shock wave, lateral impact energy, vortex flow), ultimately leading to pathophysiologically heterogeneous secondary acute cerebrovascular lesions, including ischemic stroke. Clinical cases of vasculocerebral injury are presented. Early identification of cervical and cranial vascular injuries contributes to timely and optimal treatment tactic selection (surgical, conservative, including differentiated antithrombotic therapy) and improves ischemic stroke prevention during combat operations.
- 5 November 2025
- Published by ECO-Vector LLC (Publications) in Russian Military Medical Academy Reports
- Vol. 44 (4) , 367-380
Open AccessIschemic stroke in combat conditions. Vasculocerebral injury
During armed conflicts, the incidence of ischemic stroke among military personnel increases substantially compared with peacetime. In addition to the elevated risk of combat-related injuries, military service members are exposed to intense physical and emotional stress and extreme environmental factors, which contribute to the toll of both common (atherosclerotic arterial changes, diabetes mellitus, obesity, cardiovascular diseases) and specific risk factors more typical of young adults (cardiac sources of embolism, non-inflammatory and inflammatory arteriopathies, coagulation disorders), as well as generate additional stroke risk factors unique to combat conditions. Firearm injuries have a special place in the pathogenesis of combat-related ischemic stroke. We have proposed and substantiated the term vasculocerebral injury. It is a distinct type of combat firearm injury, representing a cascade of sequential interrelated pathological changes occurring in the damaged major precerebral arteries (aorta, brachiocephalic trunk, common and internal carotid arteries, vertebral arteries), cerebral arteries, their vascular territories, blood cellular elements, and surrounding tissues as a result of the complex damaging effect of a high-energy projectile (shock wave, lateral impact energy, vortex flow), ultimately leading to pathophysiologically heterogeneous secondary acute cerebrovascular lesions, including ischemic stroke. Clinical cases of vasculocerebral injury are presented. Early identification of cervical and cranial vascular injuries contributes to timely and optimal treatment tactic selection (surgical, conservative, including differentiated antithrombotic therapy) and improves ischemic stroke prevention during combat operations.
- Open Access
- 8 December 2024
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 43 (4) , 429-438
Clinical and instrumental characteristics of mild traumatic brain injury and acubarotrauma due to the impact of an explosive shock wave
BACKGROUND: Traumatic brain injuries are widespread and need to be studied, having a serious impact on health and the economy. Every year, about 69 million people experience traumatic brain injuries, including road accidents and military conflicts. A number of studies show that up to 20% of veterans who have returned from Iraq and Afghanistan, got a mild head injury. 83% of those hospitalized between 2001 and 2018 had a mild traumatic brain injuries. Pathophysiological processes in traumatic brain injuries include axon loss and demyelination, which disrupts the functioning of neural networks and manifests itself in the form of instability, cognitive decline, and mental changes. The causes of instability can be associated with damage to the vestibular apparatus, conducting pathways and connections of the cerebellum and cortical analyzers, which can be detected by modern neuroimaging methods. Stabilometry using a power platform is a promising diagnostic method for light therapy. traumatic brain injuries, which allows you to study the equilibrium function. AIM: to determine the clinical and instrumental characteristics of mild traumatic brain injury and acubarotrauma due to the impact of a shock blast wave separately and in combination. MATERIALS AND METHODS: 66 patients were selected (n = 66) aged 18 to 56 years (38.28 ± 9.98 years) who were exposed to a shock wave. Of these, 28 (42.4%) patients with mild traumatic brain injury (group 1), 21 (31.8%) patients with isolated acubarotrauma (group 2), with a combination of mild traumatic brain injury and acubarotrauma in 17 (25.8%) patients (group 3). Age, presence of chronic diseases, neurological status, neuropsychological examination, stabilometric examination, computed tomography and magnetic resonance imaging of the brain were evaluated. The table editor (MS Excel 2019) was used for statistical data processing and the program for medical and biological research (STATISTICA 12). RESULTS: the diagnosis of mild traumatic brain injury and acubarotrauma was established based on clinical recommendations. In the neurological status of all patients in groups 1 and 3, scattered organic symptoms were detected. In group 2, patients had a few isolated unstable neurological signs. According to neuropsychological testing, there was a deterioration in the results in group 3 compared to the group 1 and 2 (p 0.05). A stabilometric study showed that in group 3 significantly worse indicators of the speed of the general center of pressure, the area of the statokinesiogram with both open and closed eyes were noted compared to the other groups (p 0.05). According to the data of magnetic resonance imaging of the brain, including using SWI/SWAN sequences, diffuse micro-hemorrhages in the brain substance were not detected in the study groups. CONCLUSION: the main characteristics of mild traumatic brain injury in combination with acubarotrauma include pronounced postural instability, deterioration of stabilometric parameters and cognitive functions.
- 8 December 2024
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 43 (4) , 429-438
Open AccessClinical and instrumental characteristics of mild traumatic brain injury and acubarotrauma due to the impact of an explosive shock wave
BACKGROUND: Traumatic brain injuries are widespread and need to be studied, having a serious impact on health and the economy. Every year, about 69 million people experience traumatic brain injuries, including road accidents and military conflicts. A number of studies show that up to 20% of veterans who have returned from Iraq and Afghanistan, got a mild head injury. 83% of those hospitalized between 2001 and 2018 had a mild traumatic brain injuries. Pathophysiological processes in traumatic brain injuries include axon loss and demyelination, which disrupts the functioning of neural networks and manifests itself in the form of instability, cognitive decline, and mental changes. The causes of instability can be associated with damage to the vestibular apparatus, conducting pathways and connections of the cerebellum and cortical analyzers, which can be detected by modern neuroimaging methods. Stabilometry using a power platform is a promising diagnostic method for light therapy. traumatic brain injuries, which allows you to study the equilibrium function. AIM: to determine the clinical and instrumental characteristics of mild traumatic brain injury and acubarotrauma due to the impact of a shock blast wave separately and in combination. MATERIALS AND METHODS: 66 patients were selected (n = 66) aged 18 to 56 years (38.28 ± 9.98 years) who were exposed to a shock wave. Of these, 28 (42.4%) patients with mild traumatic brain injury (group 1), 21 (31.8%) patients with isolated acubarotrauma (group 2), with a combination of mild traumatic brain injury and acubarotrauma in 17 (25.8%) patients (group 3). Age, presence of chronic diseases, neurological status, neuropsychological examination, stabilometric examination, computed tomography and magnetic resonance imaging of the brain were evaluated. The table editor (MS Excel 2019) was used for statistical data processing and the program for medical and biological research (STATISTICA 12). RESULTS: the diagnosis of mild traumatic brain injury and acubarotrauma was established based on clinical recommendations. In the neurological status of all patients in groups 1 and 3, scattered organic symptoms were detected. In group 2, patients had a few isolated unstable neurological signs. According to neuropsychological testing, there was a deterioration in the results in group 3 compared to the group 1 and 2 (p 0.05). A stabilometric study showed that in group 3 significantly worse indicators of the speed of the general center of pressure, the area of the statokinesiogram with both open and closed eyes were noted compared to the other groups (p 0.05). According to the data of magnetic resonance imaging of the brain, including using SWI/SWAN sequences, diffuse micro-hemorrhages in the brain substance were not detected in the study groups. CONCLUSION: the main characteristics of mild traumatic brain injury in combination with acubarotrauma include pronounced postural instability, deterioration of stabilometric parameters and cognitive functions.
- Open Access
- 11 January 2023
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 27 (6) , 70-76
Тhe clinical case of benign monomelic amyotrophy of the lower limb
The benign monomelic amyotrophy of the lower limb is a slowly progressive disease that is clinically manifested by muscle atrophy in only one lower limb. This disease is quite rare, while it is most common in Asian countries (about 80 cases have been described). According to the literature a total of 16 cases of benign monomelic amyotrophy of the lower limb were described in Europe by 2000. Etiology and pathogenesis have not been reliably studied now. The article presents a clinical case of the development of this disease in a 42-year-old patient. The patient was admitted with complaints of weakness in the right leg and its decrease in volume. During the period of hospitalization, diff erential diagnosis was carried out with amyotrophic lateral sclerosis, progressive muscle atrophy, Hirayama disease, vascular and paraneoplastic processes. According to the results of a comprehensive laboratory and instrumental examination, the diagnosis was fi rst established: benign monomelic amyotrophy of the lower limb. The father of a patient who had atrophy of the muscles of the left lower limb would also be examined. According to the data of hereditary anamnesis, an assumption was made about the presence of the phenomenon of anticipation in the inheritance of benign monomelic amyotrophy of the lower limb. This article describes for the fi rst time a case of benign monomelic amyotrophy of the lower limb in the domestic literature, as well as a familial case of this disease all over the world.
- 11 January 2023
- Published by Medical Informational Agency Publishers in Russian neurological Journal
- Vol. 27 (6) , 70-76
Open AccessТhe clinical case of benign monomelic amyotrophy of the lower limb
The benign monomelic amyotrophy of the lower limb is a slowly progressive disease that is clinically manifested by muscle atrophy in only one lower limb. This disease is quite rare, while it is most common in Asian countries (about 80 cases have been described). According to the literature a total of 16 cases of benign monomelic amyotrophy of the lower limb were described in Europe by 2000. Etiology and pathogenesis have not been reliably studied now. The article presents a clinical case of the development of this disease in a 42-year-old patient. The patient was admitted with complaints of weakness in the right leg and its decrease in volume. During the period of hospitalization, diff erential diagnosis was carried out with amyotrophic lateral sclerosis, progressive muscle atrophy, Hirayama disease, vascular and paraneoplastic processes. According to the results of a comprehensive laboratory and instrumental examination, the diagnosis was fi rst established: benign monomelic amyotrophy of the lower limb. The father of a patient who had atrophy of the muscles of the left lower limb would also be examined. According to the data of hereditary anamnesis, an assumption was made about the presence of the phenomenon of anticipation in the inheritance of benign monomelic amyotrophy of the lower limb. This article describes for the fi rst time a case of benign monomelic amyotrophy of the lower limb in the domestic literature, as well as a familial case of this disease all over the world.
- Open Access
- 6 December 2021
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 40 (4) , 43-50
The structure and risk factors of the postoperative cerebral dysfunction in oncosurgery
Aim of the research was to study the features of the structure of postoperative cerebral dysfunction, establishing the risk factors for the development of postoperative cerebral dysfunction and for the each of the clinical types during operations for malignant neoplasms of the chest and abdomen. The study was conducted in 2 stages: a retrospective study based on medical records and a prospective study. In a retrospective study by the method of directed selection from 93,129 clinical cases of patients, 47 cases of patients with acute stroke after surgery were selected. In prospective study, 102 patients (69 men, 33 women) aged 38 to 85 years were examined, the median age was 67 years. They were divided into two study groups: thoracic, abdominal. In a retrospective study, the incidence of perioperative stroke was 0.05%. In a prospective study of surgical operations for malignant neoplasms of the chest and abdomen, the incidence of postoperative cerebral dysfunction was 34%, perioperative stroke 2%, symptomatic delirium of the early postoperative period 11%, deferred cognitive impairment 31%. Statistical processing of the prospective study data revealed 10 risk factors for postoperative cerebral dysfunction, 12 risk factors for perioperative stroke, 7 risk factors for symptomatic delirium of the early postoperative period, and 6 risk factors for deferred cognitive impairment. For each of the clinical types of postoperative cerebral dysfunction the Charlson comorbidity index has a significant predictive value, and therefore it seems appropriate to include this parameter in the preoperative examination algorithm (3 tables, bibliography: 8 refs)
- 6 December 2021
- Published by ECO-Vector LLC in Russian Military Medical Academy Reports
- Vol. 40 (4) , 43-50
Open AccessThe structure and risk factors of the postoperative cerebral dysfunction in oncosurgery
Aim of the research was to study the features of the structure of postoperative cerebral dysfunction, establishing the risk factors for the development of postoperative cerebral dysfunction and for the each of the clinical types during operations for malignant neoplasms of the chest and abdomen. The study was conducted in 2 stages: a retrospective study based on medical records and a prospective study. In a retrospective study by the method of directed selection from 93,129 clinical cases of patients, 47 cases of patients with acute stroke after surgery were selected. In prospective study, 102 patients (69 men, 33 women) aged 38 to 85 years were examined, the median age was 67 years. They were divided into two study groups: thoracic, abdominal. In a retrospective study, the incidence of perioperative stroke was 0.05%. In a prospective study of surgical operations for malignant neoplasms of the chest and abdomen, the incidence of postoperative cerebral dysfunction was 34%, perioperative stroke 2%, symptomatic delirium of the early postoperative period 11%, deferred cognitive impairment 31%. Statistical processing of the prospective study data revealed 10 risk factors for postoperative cerebral dysfunction, 12 risk factors for perioperative stroke, 7 risk factors for symptomatic delirium of the early postoperative period, and 6 risk factors for deferred cognitive impairment. For each of the clinical types of postoperative cerebral dysfunction the Charlson comorbidity index has a significant predictive value, and therefore it seems appropriate to include this parameter in the preoperative examination algorithm (3 tables, bibliography: 8 refs)
- Open Access
- 7 April 2021
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 27 (1) , 29-40
The algorithm of reperfusion treatment of the ischemic stroke: focus on DAWN and DEFUSE-3 trials
The history of reperfusion treatment for ischemic stroke was officially recognized in 1996, when the use of systemic thrombolytic therapy (TLT) was authorized in the United States of America and the first clinical guidelines were published (American Heart Association (AHA) Stroke Council). The use of TLT for the treatment of ischemic stroke in the Russian Federation began in 2005–2006. The next step was the development of endovascular reperfusion techniques (2005) following the presentation of the results of the MERCI study, which evaluated the safety and efficacy of microconductors for fragmentation and destruction of blood clots. Currently, neurologists working with patients with acute cerebrovascular accidents are guided by national regulatory documents — order of the Ministry of Health of the Russian Federation dated by November 15, 2012 No. 928n “On approval of the Procedure for providing medical care to patients with acute cerebrovascular accidents” and the Protocol of reperfusion therapy acute ischemic stroke (2019), which provide basic information on the methods of diagnosis and treatment of ischemic cerebral stroke, as well as international recommendations ESO, AHA/ASA, which provide grounds for increasing therapeutic options, in particular by extending the time of the “therapeutic window”. The authors of article created the algorithm for reperfusion therapy for ischemic stroke, based on the analysis and generalization of regulatory documents, clinical guidelines and the results of DAWN and DEFUSE-3 studies.
- 7 April 2021
- Published by Arterialnaya Gipertenziya in "Arterial’naya Gipertenziya" ("Arterial Hypertension")
- Vol. 27 (1) , 29-40
Open AccessThe algorithm of reperfusion treatment of the ischemic stroke: focus on DAWN and DEFUSE-3 trials
The history of reperfusion treatment for ischemic stroke was officially recognized in 1996, when the use of systemic thrombolytic therapy (TLT) was authorized in the United States of America and the first clinical guidelines were published (American Heart Association (AHA) Stroke Council). The use of TLT for the treatment of ischemic stroke in the Russian Federation began in 2005–2006. The next step was the development of endovascular reperfusion techniques (2005) following the presentation of the results of the MERCI study, which evaluated the safety and efficacy of microconductors for fragmentation and destruction of blood clots. Currently, neurologists working with patients with acute cerebrovascular accidents are guided by national regulatory documents — order of the Ministry of Health of the Russian Federation dated by November 15, 2012 No. 928n “On approval of the Procedure for providing medical care to patients with acute cerebrovascular accidents” and the Protocol of reperfusion therapy acute ischemic stroke (2019), which provide basic information on the methods of diagnosis and treatment of ischemic cerebral stroke, as well as international recommendations ESO, AHA/ASA, which provide grounds for increasing therapeutic options, in particular by extending the time of the “therapeutic window”. The authors of article created the algorithm for reperfusion therapy for ischemic stroke, based on the analysis and generalization of regulatory documents, clinical guidelines and the results of DAWN and DEFUSE-3 studies.
- 1 January 2021
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 121 (12) , 13-18
Some psychiatric and neurological aspects of the asymptomatic and mild course of COVID-19
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить неврологические и психические нарушения, ассоциированные с инаппарантным и легким течением COVID-19. МАТЕРИАЛ И МЕТОДЫ Всего в исследование были включены 50 пациентов (средний возраст 35,2±11,4 года), госпитализированных в клинику в связи с невротическими расстройствами депрессивного спектра (РДС). Выделено две группы, основная — 16 больных, имевших IgG к возбудителю SARS-CoV-2, и группа сравнения — 34 больных, не болевших COVID-19. РЕЗУЛЬТАТЫ И ЗАКЛЮЧЕНИЕ Установлено, что у переболевших COVID-19 пациентов отмечалось отличие структуры астенических нарушений по сравнению с аналогичной группой без COVID-19 в анамнезе. Также у пациентов основной группы выявлялось значимое преобладание выраженности астенической симптоматики и тревоги в структуре психопатологических нарушений при расстройствах депрессивного спектра. Показано, что перенесенная вирусная интоксикация способствует формированию своеобразной астенической «почвы» (с характерными проявлениями). В дальнейшем в случае развития любого стресс-ассоциированного расстройства отмечаются более выраженные психопатологические нарушения по сравнению с лицами без SARS-CoV-2 в анамнезе. Выявлен вариант течения COVID-19, при котором развитие ишемического инсульта было первым клиническим проявлением заболевания. Показано, что в основе этих нарушений лежат выраженный нейротропный эффект вируса SARS-CoV-2 и его воздействие на нейрососудистую единицу.
- 1 January 2021
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 121 (12) , 13-18
Some psychiatric and neurological aspects of the asymptomatic and mild course of COVID-19
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить неврологические и психические нарушения, ассоциированные с инаппарантным и легким течением COVID-19. МАТЕРИАЛ И МЕТОДЫ Всего в исследование были включены 50 пациентов (средний возраст 35,2±11,4 года), госпитализированных в клинику в связи с невротическими расстройствами депрессивного спектра (РДС). Выделено две группы, основная — 16 больных, имевших IgG к возбудителю SARS-CoV-2, и группа сравнения — 34 больных, не болевших COVID-19. РЕЗУЛЬТАТЫ И ЗАКЛЮЧЕНИЕ Установлено, что у переболевших COVID-19 пациентов отмечалось отличие структуры астенических нарушений по сравнению с аналогичной группой без COVID-19 в анамнезе. Также у пациентов основной группы выявлялось значимое преобладание выраженности астенической симптоматики и тревоги в структуре психопатологических нарушений при расстройствах депрессивного спектра. Показано, что перенесенная вирусная интоксикация способствует формированию своеобразной астенической «почвы» (с характерными проявлениями). В дальнейшем в случае развития любого стресс-ассоциированного расстройства отмечаются более выраженные психопатологические нарушения по сравнению с лицами без SARS-CoV-2 в анамнезе. Выявлен вариант течения COVID-19, при котором развитие ишемического инсульта было первым клиническим проявлением заболевания. Показано, что в основе этих нарушений лежат выраженный нейротропный эффект вируса SARS-CoV-2 и его воздействие на нейрососудистую единицу.
- 25 April 2015
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 45 (5) , 600-604
Use of Succinates for Correction of Metabolic Impairments in the Ischemic Penumbra Zone in Stroke Patients
- 25 April 2015
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 45 (5) , 600-604
Use of Succinates for Correction of Metabolic Impairments in the Ischemic Penumbra Zone in Stroke Patients
- 1 January 2013
- Vol. 113, 55-60
[The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke].
The aim of the study was to determine the quantitative content and correlation between metabolites in the core ischemic zone, the ischemic penumbra and the intact tissue of the opposite hemisphere in the acute stage of ischemic stroke using MR-spectroscopy. We studied 72 patients, including 37 patients (the main group) treated with the antioxidant mexidol (2-ethyl-6-methyl-3-hydroxypiridine succinate) in addition to standard therapy and 35 patients who received standard therapy only. The severity of stroke was assessed using the NIHSS. The Barthel index and Rankin scale were used to evaluate functional outcome in the 30th day, hydrogen MR-spectroscopy was used twice: in the first 24 h from disease onset and in the 5th day. Mexidol used in dose 500 mg intravenously during 14 days reduced significantly the content of lactate (p=0.002) and inositol (p=0.005) in the cells compared to the control group that enhanced the restoration of the balance between aerobic and anaerobic mechanisms of oxidation and positively influenced on the rehabilitation of patients. Positive correlations between the content of lactate in the ischemic penumbra and NIHSS scores (r=0.5786; p=0.049) and the negative correlation between the content of lactate in the ischemic penumbra and the degree of functional restoration assessed by the Barthel index (r= -0.6305; p=0.028) were found. These findings support the evidence for the interaction between the disturbance of glucose metabolism in conditions of hypoxia and the degree of nervous tissue damage.
- 1 January 2013
- Vol. 113, 55-60
[The use of succinates for the correction of metabolic disorders in the penumbra in patients with stroke].
The aim of the study was to determine the quantitative content and correlation between metabolites in the core ischemic zone, the ischemic penumbra and the intact tissue of the opposite hemisphere in the acute stage of ischemic stroke using MR-spectroscopy. We studied 72 patients, including 37 patients (the main group) treated with the antioxidant mexidol (2-ethyl-6-methyl-3-hydroxypiridine succinate) in addition to standard therapy and 35 patients who received standard therapy only. The severity of stroke was assessed using the NIHSS. The Barthel index and Rankin scale were used to evaluate functional outcome in the 30th day, hydrogen MR-spectroscopy was used twice: in the first 24 h from disease onset and in the 5th day. Mexidol used in dose 500 mg intravenously during 14 days reduced significantly the content of lactate (p=0.002) and inositol (p=0.005) in the cells compared to the control group that enhanced the restoration of the balance between aerobic and anaerobic mechanisms of oxidation and positively influenced on the rehabilitation of patients. Positive correlations between the content of lactate in the ischemic penumbra and NIHSS scores (r=0.5786; p=0.049) and the negative correlation between the content of lactate in the ischemic penumbra and the degree of functional restoration assessed by the Barthel index (r= -0.6305; p=0.028) were found. These findings support the evidence for the interaction between the disturbance of glucose metabolism in conditions of hypoxia and the degree of nervous tissue damage.
- 1 January 2010
- Vol. 110 (12) , 29-36
[Efficacy of cytoflavin in patients in the acute ischemic stroke].
We present the results of a multicenter study on efficacy of cytoflavin in the treatment of patients with acute ischemic stroke. Seventy patients (41 of the main group and 29 of the control group) were enrolled in the study. All patients received basic therapy aimed at improving systemic hemodynamics, rheological blood properties and at the prevention of stroke complications. Patients of the main group were treated with cytoflavin as follows: days 1-10 - 20 ml (in 400 ml of the 0,9% NaCl solution) twice a day intravenously in drops; days 11-35 - 850 mg twice a day. We assessed the dynamics of restoration of lost functions (NIHSS, the Rankin scale, the Barthel index) and volumes of ischemic lesion (MRI T1-, T2-, diffusion-weighted images). Results of the study on patients of the control group were supplemented with literature data about 306 patients studied using clinical scales and 40 patients studied with MRI. We revealed a trend towards an effect of cytoflavin on the preservation of brain matter in the acute phase of stroke. Cytoflavin reduced the neurological deficit and improved activities of daily living in patients that may be explained by the less brain damage.
- 1 January 2010
- Vol. 110 (12) , 29-36
[Efficacy of cytoflavin in patients in the acute ischemic stroke].
We present the results of a multicenter study on efficacy of cytoflavin in the treatment of patients with acute ischemic stroke. Seventy patients (41 of the main group and 29 of the control group) were enrolled in the study. All patients received basic therapy aimed at improving systemic hemodynamics, rheological blood properties and at the prevention of stroke complications. Patients of the main group were treated with cytoflavin as follows: days 1-10 - 20 ml (in 400 ml of the 0,9% NaCl solution) twice a day intravenously in drops; days 11-35 - 850 mg twice a day. We assessed the dynamics of restoration of lost functions (NIHSS, the Rankin scale, the Barthel index) and volumes of ischemic lesion (MRI T1-, T2-, diffusion-weighted images). Results of the study on patients of the control group were supplemented with literature data about 306 patients studied using clinical scales and 40 patients studied with MRI. We revealed a trend towards an effect of cytoflavin on the preservation of brain matter in the acute phase of stroke. Cytoflavin reduced the neurological deficit and improved activities of daily living in patients that may be explained by the less brain damage.